The US Food and Drug Administration (FDA) review, which found the Johnson and Johnson (J&J) Covid-19 vaccine to be safe and efficient, paves way for the jab to being registered locally.
While results of the phase 3 J&J clinical trials have not been published locally, they are contained in the FDA report and give a glimpse into the vaccine's efficacy.
The vaccine has not yet been approved locally, but is currently being rolled out to healthcare workers as part of an implementation study - which is similar to a phase 3 clinical trial.